A Pilot Investigation of Dutasteride (Avodart) After Failure of Finasteride (Proscar) In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Dutasteride (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 19 Oct 2012 Biomarkers information updated
- 18 Oct 2012 Additional lead trial centre deleted as reported by ClinicalTrials.gov record.
- 25 Aug 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.